Standard

Эрадикационная терапия хеликобактериоза при помощи пробиотиков : проблемы и перспективы. / Ermolenko, E. I.; Molostova, A. S.; Gladyshev, N. S.

в: Eksperimental'naya i Klinicheskaya Gastroenterologiya, № 9, 2021, стр. 60-72.

Результаты исследований: Научные публикации в периодических изданиях › Обзорная статья › Рецензирование

Harvard

Ermolenko, EI, Molostova, AS & Gladyshev, NS 2021, 'Эрадикационная терапия хеликобактериоза при помощи пробиотиков: проблемы и перспективы', Eksperimental'naya i Klinicheskaya Gastroenterologiya, № 9, стр. 60-72. https://doi.org/10.31146/1682-8658-ecg-193-9-60-72

APA

Ermolenko, E. I., Molostova, A. S., & Gladyshev, N. S. (2021). Эрадикационная терапия хеликобактериоза при помощи пробиотиков: проблемы и перспективы. Eksperimental'naya i Klinicheskaya Gastroenterologiya, (9), 60-72. https://doi.org/10.31146/1682-8658-ecg-193-9-60-72

Vancouver

Ermolenko EI, Molostova AS, Gladyshev NS. Эрадикационная терапия хеликобактериоза при помощи пробиотиков: проблемы и перспективы. Eksperimental'naya i Klinicheskaya Gastroenterologiya. 2021;(9):60-72. https://doi.org/10.31146/1682-8658-ecg-193-9-60-72

Author

Ermolenko, E. I. ; Molostova, A. S. ; Gladyshev, N. S. / Эрадикационная терапия хеликобактериоза при помощи пробиотиков : проблемы и перспективы. в: Eksperimental'naya i Klinicheskaya Gastroenterologiya. 2021 ; № 9. стр. 60-72.

BibTeX

@article{d91ae77de9a84929af595c92bdf021eb,
title = "Эрадикационная терапия хеликобактериоза при помощи пробиотиков: проблемы и перспективы",
abstract = "Currently, there is an urgent question of optimizing the treatment of stomach diseases associated with Helicobacter pylori, due to the increasing resistance of the pathogen to antibiotics and the presence of side effects of standard therapy. To optimize it, it is proposed to use probiotics as an additional or monotherapy. The review presents the results of studies of anti-helicobacter activity by in vitro and in vivo systems, as well as an assessment of the clinical effectiveness of various probiotic strains of microorganisms in eradication therapy. Several mechanisms of action of probiotics in the treatment of HP-related diseases are discussed. The problems and prospects of using personalized therapy of helicobacteriosis with probiotics and autoprobiotics, based on strains obtained from the gastrointestinal tract, are indicated.",
keywords = "Autoprobiotics, Enterococcus sp., Helicobacter pylori, Lactobacillus spp., Probiotics, Saccharomyces boulardii",
author = "Ermolenko, {E. I.} and Molostova, {A. S.} and Gladyshev, {N. S.}",
note = "Publisher Copyright: {\textcopyright} 2021 Eksperimental'naya i Klinicheskaya Gastroenterologiya. All rights reserved.",
year = "2021",
doi = "10.31146/1682-8658-ecg-193-9-60-72",
language = "русский",
pages = "60--72",
journal = "Experimental and Clinical Gastroenterology",
issn = "1682-8658",
publisher = "Глобал медиа технологии",
number = "9",

}

RIS

TY - JOUR

T1 - Эрадикационная терапия хеликобактериоза при помощи пробиотиков

T2 - проблемы и перспективы

AU - Ermolenko, E. I.

AU - Molostova, A. S.

AU - Gladyshev, N. S.

N1 - Publisher Copyright: © 2021 Eksperimental'naya i Klinicheskaya Gastroenterologiya. All rights reserved.

PY - 2021

Y1 - 2021

N2 - Currently, there is an urgent question of optimizing the treatment of stomach diseases associated with Helicobacter pylori, due to the increasing resistance of the pathogen to antibiotics and the presence of side effects of standard therapy. To optimize it, it is proposed to use probiotics as an additional or monotherapy. The review presents the results of studies of anti-helicobacter activity by in vitro and in vivo systems, as well as an assessment of the clinical effectiveness of various probiotic strains of microorganisms in eradication therapy. Several mechanisms of action of probiotics in the treatment of HP-related diseases are discussed. The problems and prospects of using personalized therapy of helicobacteriosis with probiotics and autoprobiotics, based on strains obtained from the gastrointestinal tract, are indicated.

AB - Currently, there is an urgent question of optimizing the treatment of stomach diseases associated with Helicobacter pylori, due to the increasing resistance of the pathogen to antibiotics and the presence of side effects of standard therapy. To optimize it, it is proposed to use probiotics as an additional or monotherapy. The review presents the results of studies of anti-helicobacter activity by in vitro and in vivo systems, as well as an assessment of the clinical effectiveness of various probiotic strains of microorganisms in eradication therapy. Several mechanisms of action of probiotics in the treatment of HP-related diseases are discussed. The problems and prospects of using personalized therapy of helicobacteriosis with probiotics and autoprobiotics, based on strains obtained from the gastrointestinal tract, are indicated.

KW - Autoprobiotics

KW - Enterococcus sp.

KW - Helicobacter pylori

KW - Lactobacillus spp.

KW - Probiotics

KW - Saccharomyces boulardii

UR - http://www.scopus.com/inward/record.url?scp=85122071534&partnerID=8YFLogxK

U2 - 10.31146/1682-8658-ecg-193-9-60-72

DO - 10.31146/1682-8658-ecg-193-9-60-72

M3 - Обзорная статья

AN - SCOPUS:85122071534

SP - 60

EP - 72

JO - Experimental and Clinical Gastroenterology

JF - Experimental and Clinical Gastroenterology

SN - 1682-8658

IS - 9

ER -

ID: 94444235